Hong Kong Regenechel Bioscience fell the last splash for speculative shares

Holdings Regencell Bioscience HoldingsA Hong Kong Biological Company company, which has no revenue, is the newest speculative foreign action that attracts an unusual splash of trading.

Rencell stock, which states that it develops traditional Chinese herb procedures to treat childhood attention and autism, more than three times – increases more than 280% on the closure 38 by 1 split The announced on June 2 came into force. By the end of Monday, Regecell, founded in 2014 and traded on NASDAQ under “RGC” since 2021, had a total market capitalization of $ 29.7 billion, according to S&P Capital IQ.

The shares continued to jump on Tuesday, scoring more than 25%. The company’s performance for the year also comes out of the hit -parades, increasing more than 58,000% in 2025. Its current market value of $ 36 billion Lululemon, eBay and Kraft Heinz. The actions were traded for a penny at one point in the last year.

Regencell is the last example of a speculative international action that attracts attention during summer bidding. For example, in August 2022, for example Amtd DigitalFintech based in Hong Kong, rose by 126%Briefly giving it a market value more than Coca-Cola and Bank of America.

Earlier this month, Regecell explained the split of shares as developed exclusively “to increase the liquidity of the company’s ordinary shares and made stocks more accessible to investors.” The shares alloy changes nothing fundamentally about the company.

Regent also came against the background of increasing attention on alternative medicines after Robert F. Kennedya swore as secretary of the Ministry of Health and Human Services in February. Kennedy, vaccine, skeptic, took action to Discourage routine rootstock In the US, last week Removing all the panel members This advises the centers for the control and prevention of vaccine diseases.

Regencell reserves often make huge day -day swings. For example, on March 21, the shares jumped by about 30% before decreasing by 30% the next day of trade.

Incomprehensible treatments, zero profits

Despite the wild spike in the stock, little is known about the effectiveness and commercialization of the regents during the disorder of the ADHD and the autistic spectrum.

Regenechel’s business centers on its own traditional Chinese medicine formula (TCM) developed in partnership with practicing TCM Sik-Kee AU using your “Sik-Kee Au TCM brain theory.“Sik-KEE AU Father of Chief Executive Director Regencell Yat-go ay, according to a statement in 2022.

According to Factset data, the CEO manages 86.24% of the total stock.

Three liquid, oral Candidates for TCM formula Claims on resolution of light, moderate and difficult conditions and contain only natural ingredients, such as the so -called “detoxification of greenery”, blood circulation and digestive herbs.

“These TCM formulas form the basis of our TCM products, which we are going to develop and commercialize for the treatment of ADHD and TSA,” Regecell said.

In it Last annual report submitted last OctoberRegecell said he did not make any income and did not provide any regulatory statement of his TCM formulas. During the financial years ended June 2024 and 2023, Regencell suffered total net losses of $ 4.36 million and $ 6.06 million, respectively, according to 20F, which applied to the SEC.

“We have not brought income from any TCM candidates either, either addressed any regulatory allegations, and we are not able to distribute, experience, or patent, or waiting for patent applications and never be profitable,” the application said.

Regecell did not respond to the CNBC request about the comment.

Regencell’s Last study of the patientFrom November 15, 2023, it was said that 28 patients received treatment for three months in the second trial of efficiency and showed improvement of symptoms of ADHD and TSA, the company web page reports.

In the earlier case, Regents stated in 2021 Issue of the news What he treated a dozen patients with suspected or confirmed COVID-19 cases, using a modified version of a modified cold formula and the flu. What has been described as an improvement in the conditions led to the regents to the creation of a joint venture from the Honor Epic Enterprises Limited in September 2021 to conduct further tests and commercialization of the company in ASEAN countries, the statement said.

Internet

Over the past few years, the action has attracted a small chatter on social media. Those comments that have been made testify to the hobbies of the retailer – and skepticism.

One user on the Reddit page “R/Shortsqueeze” On Monday, he wrote that Regencell “traded like a meme. Another user said in a message made three months ago: “I every day Scalp RGC for a little profit.” In May alone, the shares jumped by 1.360%.

At LinkedIn in May, one investor said he ‘Can’t stop laughing“After reading the description of the company. Another post of User in the pharmaceutical industryAccording to his profile, last week stated that Regentsel became a “action that should be observed” after his spike in May “there is no official news and catalysts.” Another LinkedIn user commented on Regencell last month, saying: “Chinese, low volume and official news, Bizarro”.

On x, one user wrote in a message on Monday, ‘for #Completebullsh__companyoftheyar I will highlight Regencell. “

– Scott Schnipp in CNBC made a report.